Showing results (131-140 of 145) with videos related to

Sort By:
Pageof 15
BMC Pediatrics|August 17, 2023
A pediatric virtual care evaluation framework and its evolution using consensus methodsCatherine Dulude, Stephanie Sutherland, Shelley Vanderhout, et al.
The International Journal of Behavioral Nutrition and Physical Activity|July 7, 2022
The structured health intervention for truckers (SHIFT) cluster randomised controlled trial: a mixed methods process evaluationAmber J Guest, Nicola J Paine, Yu-Ling Chen, et al.
Medicine and Science in Sports and Exercise|January 3, 2020
Predictors of the Acute Postprandial Response to Breaking Up Prolonged SittingJoseph Henson, Charlotte L Edwardson, Carlos A Celis-Morales, et al.
Nature Communications|June 1, 2022
A calcium-based plasticity model for predicting long-term potentiation and depression in the neocortexGiuseppe Chindemi, Marwan Abdellah, Oren Amsalem, et al.
British Paramedic Journal|March 6, 2024
The COVID-19 ambulance response assessment (CARA) study: a national survey of ambulance service healthcare professionals' preparedness and response to the COVID-19 pandemicJack William Barrett, Kate Bennett Eastley, Anthony Herbland, et al.
Plos One|June 27, 2014
A GPBAR1 (TGR5) small molecule agonist shows specific inhibitory effects on myeloid cell activation in vitro and reduces experimental autoimmune encephalitis (EAE) in vivoNuruddeen D Lewis, Lori A Patnaude, Josephine Pelletier, et al.
Hypertension (Dallas, Tex. : 1979)|March 4, 2026
Big Data Approach to Assessment of an Aldosterone-Renin Ratio for Detection of Potential Surgical Cases of Primary AldosteronismAlexander A Leung, Joshua J Burkart, Joshua Low, et al.
Nature|May 21, 2020
TASL is the SLC15A4-associated adaptor for IRF5 activation by TLR7-9Leonhard X Heinz, JangEun Lee, Utkarsh Kapoor, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|September 8, 2021
The potent and selective RIPK2 inhibitor BI 706039 improves intestinal inflammation in the TRUC mouse model of inflammatory bowel diseaseJoerg Ermann, Mederbek Matmusaev, Emma K Haley, et al.
The Journal of Infectious Diseases|January 28, 2004
Phase 2 evaluation of parainfluenza type 3 cold passage mutant 45 live attenuated vaccine in healthy children 6-18 months oldRobert B Belshe, Frances K Newman, Theodore F Tsai, et al.
Pageof 15